Marco Benazzo

Dr. Marco Benazzo


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2012
Verified
Journal Article
Closed access
NMNiccolò Mevio
Niccolò Mevio
Giulia BertinoGiulia Bertino
Giulia Bertino
AOAntonio Occhini
Antonio Occhini
DSDaniele Scelsi
Daniele Scelsi
MTMarta Tagliabue
Marta Tagliabue
MBMarco Benazzo
Marco Benazzo

1 May 2015 in Human Pathology
Verified
Journal Article
Closed access
PMPatrizia Morbini
Patrizia Morbini
PAPaola Alberizzi
Paola Alberizzi
CTCarmine Tinelli
Carmine Tinelli
CPChiara Paglino
Chiara Paglino
Giulia BertinoGiulia Bertino
Giulia Bertino
MBMarco Benazzo
Marco Benazzo

17 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SDSara Demurtas
Sara Demurtas
Hellas CenaHellas Cena
Hellas Cena
MBMarco Benazzo
Marco Benazzo
PGPaola Gabanelli
Paola Gabanelli
SPSimone Porcelli
Simone Porcelli
LLLaura Locati
Laura Locati
Cancer prehabilitation is the process between the time of cancer diagnosis and the beginning of the active acute treatment; prehabilitation consists of various need-based interventions, e.g., physical activity, a nutritional program, and psychological support. It can be delivered as unimodal or multimodal interventions. Physical activity, including resistant exercise and aerobic activities, has to be tailored according to the patient’s characteristics; nutritional support is aimed at preventing malnutrition and sarcopenia; while psychological intervention intercepts the patient’s distress and supports specific intervention to address it. In addition, multimodal prehabilitation could have a potential impact on the immune system, globally reducing the inflammatory processes and, as a consequence, influencing cancer progression. However, many challenges are still to be addressed, foremost among them the feasibility of prehabilitation programs, the lack of adequate facilities for these programs’ implementation, and the fact that not all prehabilitation interventions are reimbursed by the national health system.

7 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMarco Benazzo
Marco Benazzo
PCPietro Canzi
Pietro Canzi
SMSimone Mauramati
Simone Mauramati
FSFabio Sovardi
Fabio Sovardi
AOAntonio Occhini
Antonio Occhini
PMPatrizia Morbini
Patrizia Morbini
Background: Monopolar electrocautery (EC) is the surgical cutting and haemostatic tool most commonly used for transoral robotic surgery (TORS). The aim of this study was to retrospectively compare EC efficacy in the treatment of patients affected by T1 or T2 oropharyngeal and supraglottic squamous cell carcinomas with the more recently introduced laser fibres. Methods: We considered all TORS patients admitted to our department from January 2010 to June 2019. The outcomes of patients treated with Thulium: yttrium aluminium garnet (YAG) laser (TY-TORS), CO2 laser (CO2-TORS) and EC (EC-TORS) were analysed in order to assess surgical performances, functional outcomes and postoperative complications. Results: Twenty patients satisfied the enrolling criteria, of which nine underwent laser-TORS, and the remaining 11 underwent EC-TORS. In all candidates, TORS procedures were completed without the need for microscopic/open conversion. Close or positive margins were significantly more frequent in EC-TORS (p = 0.028). A considerable difference was found in overall functional parameters: times of nasogastric tube and tracheostomy removal and time of hospital discharge were significantly shorter in laser-TORS (p = 0.04, p = 0.05, p = 0.04, respectively). Conclusions: Laser-TORS showed better results in comparison with EC-TORS in term of tumour resection margins and patient functional outcomes. Our findings can be justified with the greater tissue thermal damage caused by EC-TORS, despite prospective randomized trials and increased patient numbers being needed to confirm these preliminary conclusions.

Verified
Journal Article
Open access
PDF file
Luigi RuccoloLuigi Ruccolo
Luigi Ruccolo
AEAleksandra Evangelista
Aleksandra Evangelista
MBMarco Benazzo
Marco Benazzo
Bice ContiBice Conti
Bice Conti
Silvia PisaniSilvia Pisani
Silvia Pisani
Neural tissue injuries, including spinal cord damage and neurodegenerative diseases, pose a major clinical challenge due to the central nervous system’s limited regenerative capacity. Current treatments focus on stabilization and symptom management rather than functional restoration. Tissue engineering offers new therapeutic perspectives, particularly through the combination of electrospun nanofibrous scaffolds and mesenchymal stem cells (MSCs). Electrospun fibers mimic the neural extracellular matrix, providing topographical and mechanical cues that enhance MSC adhesion, viability, and neural differentiation. MSCs are multipotent stem cells with robust paracrine and immunomodulatory activity, capable of supporting regeneration and, under proper stimuli, acquiring neural-like phenotypes. This systematic review, following the PRISMA 2020 method, analyzes 77 selected articles from the last ten years to assess the potential of electrospun biopolymer scaffolds for MSC-mediated neural repair. We critically examine the scaffold’s composition (synthetic and natural polymers), fiber architecture (alignment and diameter), structural and mechanical properties (porosity and stiffness), and biofunctionalization strategies. The influence of MSC tissue sources (bone marrow, adipose, and dental pulp) on neural differentiation outcomes is also discussed. The results of a literature search show both in vitro and in vivo enhanced neural marker expression, neurite extension, and functional recovery when MSCs are seeded onto optimized electrospun scaffolds. Therefore, integrating stem cell therapy with advanced biomaterials offers a promising route to bridge the gap between neural injury and functional regeneration.

26 April 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MBMarco Benazzo
Marco Benazzo
FSFabio Sovardi
Fabio Sovardi
LPLORENZO PREDA
LORENZO PREDA
SMSimone Mauramati
Simone Mauramati
SCSergio Carnevale
Sergio Carnevale
PMPatrizia Morbini
Patrizia Morbini
Background: Preoperative imaging impacts treatment planning and prognosis in laryngeal cancers. We investigated the accuracy of standard computed tomography (CT) in evaluating tumor invasions at critical glottic areas. Methods: CT scans of glottic cancers treated by partial or total laryngectomy between Jan 2015 and Aug 2019 were reviewed to assess levels of tumor invasion at critical glottic subsites. CT accuracy in the identification of tumor extensions was determined against the gold standard of histopathological analysis of surgical samples. Results: This study included 64 patients. In the anterior commissure, CT showed high rates of false positives at all levels (sensitivity 56.2–70%, specificity 87.8–92.3%); in the anterior vocal fold, it overestimated the deep invasion (19.5% specificity, 90.3% sensitivity), while it underestimated the extralaryngeal spread (63.6% sensitivity, 98.1% specificity). In the posterior paraglottic space (pPGS), false negative results were more frequent for superficial extensions (25% sensitivity, 95.8% specificity) and deep invasions (58.8% sensitivity, 82.3% specificity). Shorter disease-specific and disease-free survivals were associated with pStage IV (p: 0.045 and 0.008) and with the pathological involvement of pPGS (p: 0.045 and 0.015). Conclusions: Negative prognostic correlation of pPGS involvement was confirmed on histopathological data. CT staging did not provide a satisfactory prognostic stratification and should be complemented with magnetic resonance imaging.